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Sepsis and septic shock threaten the survival of millions of patients in the intensive care
unit. Secondary fungal infections significantly increased the risk of mortality in sepsis
patients. Chinese medicine Xuebijing injection (XBJ) has been routinely used as an add-on
treatment to sepsis and septic shock in China. Our network pharmacology analysis
predicted that XBJ also influences fungal infection, consisting with results of pioneer
clinical studies. We conducted in vivo and in vitro experiments to verify this prediction. To
our surprise, XBJ rescued mice from lethal Candida sepsis in a disseminated Candida
albicans infection model and abolished the colonization of C. albicans in kidneys. Although
XBJ did not inhibit the growth and the virulence of C. albicans in vitro, it enhanced the
viability of 293T cells upon C. albicans insults. Further RNA-seq analysis revealed that
XBJ activated the endoplasmic reticulum (ER) stress pathway upon C. albicans infection.
Western blot confirmed that XBJ maintained the expression of GRP78 in the presence
of C. albicans. Interestingly, key active ingredients in XBJ (C0127) mirrored the effects
of XBJ. C0127 not only rescued mice from lethal Candida sepsis and prevented the
colonization of C. albicans in kidneys, but also sustained the survival of kidney epithelial
cells partially by maintaining the expression of GRP78. These results suggested that XBJ
may prevent fungal infection in sepsis patients. Pre-activation of ER stress pathway is a
novel strategy to control C. albicans infection. Network pharmacology may accelerate
drug development in the field of infectious diseases.
Keywords: fungal infection, C. albicans, Xuebijing injection, endoplasmic reticulum stress, GRP78, Chinese
medicine

HIGHLIGHTS
1. Xuebijing (XBJ) prevented Candida sepsis in a murine model.
2. XBJ maintained GRP78 expression to prevent C. albicans–induced kidney epithelial death.
3. The key compounds in XBJ suppressed Candida sepsis and kidney failure partially by regulating
GRP78.
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INTRODUCTION

sepsis and septic shock individually (Jiang et al., 2013; Chen
et al., 2018). Four classes of compounds from five different
herbs in XBJ may be important for its antiseptic effect (Li et al.,
2016). Intensive research is going on to identify major active
compounds in XBJ that can effectively treat sepsis (Cheng et al.,
2016; Li et al., 2016). Combining Xuebijing with anti-fungal
agents or antibiotics had positive impacts on the quality of life
of patients suffering invasive fungal infections in several clinical
studies and may improve the survival of patients (Gao, 2010;
Wang, 2010; Cao, 2017). However, it was not clear whether XBJ
can influence fungal infection individually.
Our network pharmacology analysis predicted that XBJ not
only affects therapeutic targets of sepsis but also influences
fungal infection, suggesting XBJ may prevent fungal infection
in sepsis patients. Here we reported that XBJ prevented systemic
C. albicans infections. Notably, XBJ pretreatment protected
70% of mice from mortality after systemic C. albicans infection.
It prevented the colonization of C. albicans in kidneys and
enhanced the viability of kidney epithelial cells by sustaining ER
stress signaling.

Fungal infection causes an annual mortality of 1.5 million
people worldwide (Wirnsberger et al., 2016). The cost of treating
invasive fungal infection is over 2 billion dollars in the US
(Pfaller and Diekema, 2010). As the leading pathogen in patients
suffering invasive fungal infections, Candida albicans fostered
50% of candida sepsis cases (Pfaller and Diekema, 2010; Brown
et al., 2012). Associated with a mortality rate exceeding 40%, past
decades witnessed a dramatic rise in the incidence of invasive
candidiasis (Kullberg and Arendrup, 2015).
Limited choices of antifungal drugs are available to treat
fungal infections with only two non-toxic antifungal classes for
candidiasis (Diekema et al., 2012). Azoles are applied in clinical
practice to treat C. albicans–related infections (Sakagami et al.,
2018). Nevertheless, invasive C. albicans infection still claims
mortality of 45% to 75% (Brown et al., 2012). Emerging drugresistant fungal infections are also calling for novel management
strategies to restrain fungal sepsis (Healey et al., 2016).
C. albicans–induced kidney failure is a major cause of
mortality in C. albicans sepsis (Spellberg et al., 2005). Enhancing
the function of the innate immune system rescued lethal
C. albicans infections in murine models (Xiao et al., 2016;
Dominguez-Andres et al., 2017). Other potential mechanisms
remain elusive. Administrating mirR-124 and mirR-204 mimics
prevented C. albicans–induced acute kidney injury (Li et al.,
2014b; Li et al., 2018).
Secretory and membrane proteins are synthesized and
modified in the endoplasmic reticulum (ER) of mammalian cells
(Yu et al., 2015; Zhu and Lee, 2015). Activating ER stress signaling
renders survival advantage for tissues and cells upon C. albicans
infection. Glucose-regulated proteins (GRPs) are constitutively
expressed in cells to maintain cellular homeostasis, belonging
to the heat shock protein family as stress-inducible chaperones.
Infections activate GRPs to translocate in the cells to assume
functions such as regulating signaling transduction, proliferation
and immunity (Zhu and Lee, 2015; Lewy et al., 2017). Conserved
from yeast to human, GRP78 (BiP) is one of such proteins that
regulate homeostasis of organs from endoderm, mesoderm,
and ectoderm. Interestingly, GRP78 cross-talks with PI3K/AKT
pathway, which sustains cell survival (Shani et al., 2008; Gray
et al., 2013; Liu et al., 2013).
Xuebijing (XBJ) injection was prepared with extracts from
five different Chinese herbs [Carthamus tinctorius flowers
(Honghua), Paeonia lactiflora roots (Chishao), Ligusticum
chuanxiong rhizomes (Chuanxiong), Angelica sinensis roots
(Danggui), and Salvia miltiorrhiza roots (Danshen)] (Cheng
et al., 2016; Li et al., 2016; Li et al., 2019; Zhang et al., 2018).
Approved by the Food and Drug Administration of China
in 2004, XBJ has been frequently used as an add-on therapy
for multiple organ dysfunction syndromes, sepsis, and septic
shock in China for over a decade (Chen et al., 2018a; Gao et al.,
2015; Shi et al., 2017). It rendered a series of benefits for sepsis
patients, including reducing 28-day mortality and incidence of
complications, shortening dwelling time in the intensive care
unit (Gao et al., 2015; Shi et al., 2017; Song et al., 2019). Preclinical studies indicated XBJ might be a treatment option for
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METHODS
Chemicals and Reagents

Xuebijing injection (catalog number: z20039833, batch
number: 1606121) was manufactured by Tianjin Chase Sun
Pharmaceutical Co., Ltd (Tianjin, China). This Chinese medicine
is approved by the China Food and Drug Administration (CFDA)
for treating sepsis and septic shock with the CFDA ratification
number of GuoYaoZhunZi-Z20039833 for market approval as a
drug product. It is routinely used as an add-on to conventional
therapy for treating sepsis and septic shock in China (Jiang et al.,
2013; Chen et al., 2018; Li et al., 2019). This injection contains
extracts of five herbs, including Carthamus tinctorius flowers
(Honghua in Chinese), Paeonia lactiflora roots (Chishao in
Chinese), Ligusticum chuanxiong rhizomes (Chuanxiong in
Chinese), Angelica sinensis roots (Danggui in Chinese), and
Salvia miltiorrhiza roots (Danshen in Chinese).
Methods of extraction, preparation, and quality control of XBJ
were the same as previously reported (Huang et al., 2011; Chen
et al., 2016; Li et al., 2016; Zhang et al., 2018). Briefly, ingredients
from Carthamus tinctorius flowers (“Honghua” in Chinese) were
first extracted with ethanol then with water. Ingredients from
the other four herbs were extracted with water. Finally, XBJ was
standardized to contain 1.0 to 1.7 mg/ml of paeoniflorin and 0.2
to 0.5 mg/ml of hydroxysafflor yellow A as described (Huang
et al., 2011; Chen et al., 2016; Li et al., 2016).
GRP78 inhibitor HA15 and other chemicals used in the
experiments were ordered from Sigma-Aldrich (Shanghai,
China) unless indicated. Paeoniflorin (Cas #: 23180-57-6),
hydroxysafflor yellow A (Cas#: 78281-02-4), ferulic acid (Cas
#:537-98-4), and protocatechualdehyde (Cas#:139-85-5) were
purchased from Shanghai Yuanye Biotechnology Co., Ltd.
(Shanghai, China). C0127 was prepared with paeoniflorin,
hydroxysafflor yellow A, ferulic acid, and protocatechualdehyde
according to reported concentrations in XBJ and manufacturer’s
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quality control information (Liu et al., 2015; Zuo et al., 2017;
Zuo et al., 2018). The structures of the four compounds in C0127
were presented in Supplementary Figure 1. Western blotting
was performed using the GRP78 monoclonal antibody and
tubulin monoclonal antibodies (Abcam, USA).

compound was transferred into PubChem CID or CAS number
which could be recognized by the IPA software. Furthermore,
corresponding targets of XBJ ingredients that were not recorded
by the IPA database were supplemented by literature from
PubChem and databases of TCMID and TCMSP. In total, three
datasets including XBJ ingredients, fungal infection associated
targets, and corresponding targets of XBJ’s major ingredients
were constructed and then uploaded into the IPA system
to visualize the discovery. The relationships between fungal
infection-related targets and XBJ ingredients were discovered
by “Build-Path Explorer” module. “Build-Connection” module
was implemented to interpret the relationship between targets.
“Overlay-Canonical Pathway” module was used to generate the
resulting canonical pathways. “Build-Diseases & Functions”
module was exploited to build the targets-related diseases and
functions. We utilized the “Core analysis” module to analyze the
correlation of the established network to acquire top diseases, top
functions, top pathways, and top upstream regulators. Certain top
upstream regulators were defined by the “Upstream Regulator”
module. The “Path designer” module was performed to clarify
the network. Upstream regulators analyses were performed to
elucidate the causal inference of upstream biological causes and
probable downstream effects on cellular and organismal biology
(Kramer et al., 2014). “Path designer” module was used to
demonstrate the network. The algorithm of the network analysis
was based on Fisher’s exact test with the enrichment score of
P-values in this study.

C. albicans Strain and Growth Conditions

C. albicans strain SC5314 (ATCC, USA), which was routinely
cultivated in YPD (1% yeast extract, 2% peptone, 2% glucose),
was used for all experiments in this study. The C. albicans cells
were cultured overnight at 30°C and washed twice with PBS for
further use.

Animal Experiments and Ethics Statement

This study was carried out in accordance with the recommendations
of the Guide for the Care and Use of Laboratory Animals (NIH
Publication No. 85-23, revised 1996, USA) and the recommendations
in the Guidance for the Care and Use of Laboratory Animals
issued by the Ministry of Science and Technology of China. All
experiments were approved by the Institutional Animal Care and
Use Committee of Nankai University and the Laboratory Animal
Ethics Committee of the Tianjin University of Traditional Chinese
Medicine (Tianjin, China) and were performed in accordance with
its guidelines (Permit Number: TCM-LAE-20170017). Five to six
week-old ICR female mice were used for in vivo experiments (Dong
et al., 2017). The mice were provided with free access to food and
sterile water and were caged under controlled temperature (23°C ± 2°C)
and humidity (60% ± 5%) with an artificial 12 h light/dark cycle. The
mice were randomly divided into six groups (n = 15 in each group)
as follows: Control group injected with normal saline; CA group
was infected with 5 × 106 colony-forming units of C. albicans via
tail-vein injection. XBJ group treated with XBJ (6 ml/kg; Chase Sun
Pharmaceutical, Ltd., Tianjin, China) by subcutaneous injection;
CA+XBJ group infected with C. albicans and co-treated with XBJ
(6 ml/kg); C0127 group infected with C. albicans after 3 injections
of C0127 (6 ml/kg). XBJ and C0127 were administered once/day
from Day -3 to Day -1 before the C. albicans infection. The C.
albicans strain SC5314 was cultivated in YPD (1% yeast extract, 2%
peptone, and 2% dextrose) broth with overnight shaking at 30˚C.
The systemic fungal infection and virulence assays were performed
as described (Dong et al., 2017; Liang et al., 2018).

RNA Isolation, RNA-seq, and Quantitative
Real-Time Polymerase Chain Reaction

Total RNA was extracted by the phenol-chloroform method as
previously described (Dong et al., 2017). The overall quality of
RNA was determined by A260/A280 and analyzed by agarose
gel electrophoresis. Roche GS-FLX 454 pyrosequencing was
carried out using Illumina HiSeq™ 2000 (Oebiotech Company,
China). Reverse transcriptions were conducted with an Oligo
(dT)-primed RT reagent Kit (Promega, USA). Quantitative
real-time polymerase chain reaction (PCR) was performed in
triplicate and repeated in three independent experiments with
the Mastercycler ep realplex system. Independent reaction
mixtures were carried out with the same DNA template for both
the genes of interest and the GAPDH reference gene using the
RealMasterMix (SYBR Green) Kit (Trans-Gen Biotech, China)
according to the instructions. The relative fold changes in gene
expression were determined by the 2-delta delta Ct method. Data
were presented as means ± SD of three independent experiments.

Database Construction and Network
Analysis

Fungal infection-related targets were mainly integrated from
literature mining, GeneCards (Stelzer et al., 2011) and Ingenuity
Pathway Analysis (IPA, http://www.ingenuity.com) database
(Kramer et al., 2014). Repetitive genes were automatically
identified and removed by IPA software. In addition, ingredients
derived from XBJ were collected from literature mining (Huang
et al., 2011; Jiang et al., 2013; Guo et al., 2014; Han et al., 2017;
Zuo et al., 2017; Zuo et al., 2018) and several TCM databases,
such as TCMID (Xue et al., 2013) and TCMSP (Ru et al., 2014).
Compounds that had more than 10 targets in mammalians
were selected for further analysis. The chemical name of each

Frontiers in Pharmacology | www.frontiersin.org

Hematoxylin and Eosin Staining

Hematoxylin and eosin (H&E) staining was conducted as
described (Dong et al., 2017). Briefly, kidney tissues were
collected 4 days after C. albicans infection and were fixed with
4% formalin at room temperature for 24 h, dehydrated with
alcohol, and paraffin−embedded. The tissues were then cut into
5-µm-thick sections, which were stained with H&E at room
temperature for 1 to 2 min and visualized under a microscope
(BX53, Olympus, Japan).
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Western Blotting

and tissue injuries (Wang et al., 2015; Xu et al., 2015; Chen et al.,
2018; Hu et al., 2018; Tian et al., 2018). We conducted network
pharmacology analysis to explore novel applications of XBJ. A
library of 170 proteins/molecules related to fungal infection
was built and top upstream regulators of these proteins were
identified by IPA software (Figure 1A and Supplementary
Table 1). Toll-like receptors (TLR2, TLR4), pro-inflammatory
cytokines [tumor necrosis factor, interleukin 6 (IL-6), IL-1, and
interferons], nuclear factor κB signaling, and HMGB1 were
among top upstream regulators of the targets in fungal infection
(Figures 1B, C). Interestingly, many of these molecules are
known as Xuebijing targets (Jiang et al., 2013; Chen et al., 2018).
These results indicated that XBJ may impact fungal infection.
Pathway analysis revealed that HMGB1 signaling is among the
top 4 pathways in fungal infection (Figure 2A). This echoes the
reports that XBJ may target HMGB1 to attenuate organ injuries
(Wang et al., 2007; Wang et al., 2015; Chen et al., 2016). In
addition, multiple potential targets are related to inflammation
and cell survival in the functional analysis (Figure 2B).
A further analysis predicted that 36 compounds derived from
five herbs in XBJ regulate over 70 molecules related to fungal
infection (Figure 3A). Indeed, many key upstream regulators
among these molecules were XBJ targets (Figures 3B, C). IPA

Protein was extracted from 293T cells using the RIPA solution.
The protein concentration of the lysates was measured with the
Bradford assay. Western blotting was conducted as described (Fu
et al., 2007).

Statistical Analysis

Data were presented as the mean ± standard deviation for each
group. All statistical analyses were performed using PRISM version
5.0 (GraphPad Software, Inc., La Jolla, CA, USA). Inter-group
differences were analyzed using one-way analysis of variance,
followed by Tukey’s post-hoc test for multiple comparisons. The
log-rank test was used to compare group survival trends. P < 0.05
was considered to indicate a statistically significant difference.

RESULTS
Network Pharmacology Analysis Predicted
That XBJ May Regulate Fungal Infection

Effective in controlling systemic bacterial infection, XBJ has
potentials in treating a series of diseases related to infections

FIGURE 1 | Target proteins related to fungal infection were identified in network pharmacology analysis. (A) Protein-protein interactions of the potential and proved
therapeutic targets in fungal infection. The top ten targets predicted by IPA were marked in saffron yellow and the top 20 molecules were labeled with purple-red.
(B) Top 20 upstream regulators of the potential and proved therapeutic targets in fungal infection and their relationships with the related targets. The top ten
upstream regulators predicted by IPA were marked in saffron yellow and the top 20 targets were marked in purple-red. (C) The network among top 20 upstream
regulators of the potential and proved therapeutic targets in fungal infection predicted by IPA.

Frontiers in Pharmacology | www.frontiersin.org
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FIGURE 2 | Functional analysis and pathway analysis of 170 potential therapeutic targets in fungal infection. (A) The top 20 related pathways among molecules
relevant to fungal infection. (B) Functional analysis of the 170 fungal infection target proteins. The top 20 pathways/functions were ranked from left to right by –log (P
value) and the ratio (yellow line) referred to the proportion of 170 molecules in the respective pathway.

pathway analysis foretold that these 36 compounds targeted
HMGB1, IL-6, and signaling related to organ injuries which were
among the top 20 pathways (Figures 4A, B). Our functional
analysis predicted that XBJ targets play roles in cell activation,
survival, and apoptosis (Figures 4C, D). Based on these results,
we hypothesized that XBJ prevents fungal infection and decided
to test this hypothesis in a well-established C. albicans sepsis
model (Dominguez-Andres et al., 2017; Zhao et al., 2017).

indicating the mechanism is related to the defense system in
hosts. The functional analysis by IPA predicted that XBJ targets
signaling pathways involved in organ damage and cell death
(Figures 4C, D). This is consistent with clinical observations
(Shi et al., 2017; Song et al., 2018). Thus, we hypothesized that
XBJ improves the survival of C. albicans–infected mice partially
through protecting kidneys.

XBJ Prevented C. albicans Colonization in
the Kidney

Xuebijing Prevented C. albicans–Induced
Septic Shock in a Murine Model

To determine whether C. albicans colonizes kidney after XBJ
intervention, we conducted a histopathological analysis of mouse
kidneys, and determined the fungal load in kidneys 4 days after
C. albicans infection. While hyphae, neutrophil penetration,
and tissue damages were detected in kidneys of the control
group, few hyphae were detected in the XBJ treated group.
Neutrophil penetration and tissue damage were also reduced
in the XBJ treated group (Figure 7C), suggesting XBJ inhibited
C. albicans colonization in kidneys. Consistently, the kidney
fungal burden decreased threefold in XBJ treated mice in the

All infected mice died 8 days after systemic C. albicans
infection. 6 ml/kg XBJ pre-treatment for 3 days rescued ~70%
of C. albicans infected mice from acute death (Figure 5A),
indicating that it may prevent systemic C. albicans infection
to arrest the consequent acute death. To address the question
of whether XBJ directly affects the growth of C. albicans, we
treated C. albicans in culture with different dilutions of XBJ
(from 1:100 to 1:1000). However, XBJ did not affect the growth
of C. albicans and hyphal development (data not shown),

Frontiers in Pharmacology | www.frontiersin.org
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FIGURE 3 | XBJ ingredients regulate potential therapeutic targets of fungal infection. (A) XBJ ingredient-target network predicted by IPA. Thirty-six compounds from
XBJ were predicted to cooperatively modulate 72 fungal infection-related targets. (B) Top 20 upstream regulators of potential XBJ targets in fungal infection (top 20
regulators were marked with saffron yellow and top 10 key molecules were labeled with purple-red). (C) The IPA-predicted network of top 20 upstream regulators of
potential XBJ targets shown in Figure 3B.

Key Ingredients in XBJ Rescued Mice
From Septic Shock and Prevented the
Colonization of C. albicans in the Kidney

colony-forming assay (Figure 5B). No C. albicans was detected
in blood and kidney tissues 3 weeks after the infection in XBJ
treated mice (data not shown). Next, we determined the effect
of XBJ on kidney epithelial cell survival in different conditions.
XBJ treatment at 1:100 dilution did not affect the survival of 293T
cells. However, it significantly reduced cell death from ~35% to
15% upon C. albicans infection (Figure 5C).

Network pharmacology analysis suggested that four major
compounds in XBJ may regulate most XBJ targets related to
fungal infection (Supplementary Figure 2). To understand the
mechanism of XBJ on improving the survival in C. Albicans
sepsis, C0127, a formula comprised of the four major active
compounds from XBJ, was used to treat mice before the systemic
C. albicans infection. Similar to XBJ, pre-treatment with C0127
not only significantly improved the survival of C. albicans
infected mice but also decreased fungal loads in kidneys (Figures
7A, B). Similarly, hyphae and neutrophils infiltration can hardly
be detected 4 days after C. albicans infection following the C0127
pre-treatment (Figure 7C).

XBJ Up-Regulated the ER Stress Signaling
Pathway During C. albicans Infection

To determine how XBJ protects kidney cells, 293T cells under
different treatments were subjected to RNA-seq analysis,
including cells treated with saline, cells treated with XBJ only,
cells infected with C. albicans only, and cells infected with C.
albicans in the presence of XBJ (1:100 dilution). While C. albicans
infection inhibited the ER stress signaling, XBJ treatment
restored the expression of ER stress signaling. XBJ up-regulated
the ATF6B and GRP170 on the mRNA level (Figures 6A, B). This
was further confirmed by Western blot of GRP78. XBJ restored
GRP78 expression to a similar level as control groups (noninfected 293T cells and non-infected 293T cells treated with XBJ)
(Figure 6C). Therefore, XBJ may maintain the expression of the
key factors in the ER stress signaling pathway to improve kidney
epithelial cell survival.

Frontiers in Pharmacology | www.frontiersin.org

Key Ingredients in XBJ Up-Regulated
GRP78 to Improve 293T Cell Survival Upon
C. albicans Infection

Like XBJ, C0127 maintained GRP78 expression on the protein
level in 293T cells upon the C. albicans insult (Figures 8A, B). In
our preliminary study, HA15, a GRP78 specific inhibitor (Cerezo
et al., 2016; Ruggiero et al., 2018), induced apoptosis in 293T cells
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FIGURE 4 | Functional and pathway analysis of potential XBJ targets in fungal infection. (A, B) Pathway analysis of XBJ targets in fungal infection. (A) The relationships
of potential XBJ targets and top 20 related pathways. (B) The ranking of the top 20 signaling pathways of potential XBJ targets was presented. The top 20 signaling
pathways of potential XBJ targets in fungal infection were ranked from left to right by –log (P value). (C, D) Functional analysis of XBJ targets in fungal infection.
(C) The target-function network was presented with the top 20 functions marked in saffron yellow. (D) The ranking of the top 20 functions of potential XBJ targets
was presented. The top 20 related functions were ranked from left to right by –log (P value).

FIGURE 5 | XBJ pre-treatment inhibits the colonization of C. albicans in the kidney. (A) The survival curves of XBJ pre-treated and control mice after systemic C.
albicans infection. XBJ (6 ml/kg) or 0.9% NaCl was administered by abdominal injections once/day for 3 days before systemic C. albicans infection to the treatment
group or the control group. (B) The colony-forming assay to determine the fungal loads in the kidneys of control and XBJ treated mice. Kidney tissues from control
and XBJ treated kidneys were harvested and subjected to C. albicans culture 4 days after the infection. Colonies were counted after 48 h of culture. (C) PI staining
was used to determine the effect of XBJ on the survival of 293T cells 8 h after the C. albicans infection. *P < 0.05.

induced cell death in the presence of XBJ and C0127, indicating
GRP78 is an important downstream effector of XBJ and C0127
for the survival of kidney cells (Figure 8D).

in low-serum culture (data not shown). To determine whether
GRP78 is required for the protective effect of XBJ and C0127,
293T cells were treated with HA15 upon C. albicans infection. It

Frontiers in Pharmacology | www.frontiersin.org

7

January 2020 | Volume 10 | Article 1416

Shang et al.

Xuebijing Prevents Candida sepsis

FIGURE 6 | XBJ up-regulates the ER stress signaling pathway during C. albicans infection. Six groups of 293T cells in different conditions were subjected to RNAseq analysis, including cells treated with XBJ only, infected with C. albicans, 293T cells infected with C. albicans in the presence of XBJ (1:100 dilution). (A, B) RNAseq results of ATF6B and GRP170, two genes in the ER stress pathway. (C) Western blot to determine the expression of GRP78 expression in different conditions in
293T cells. Data were representative of at least three independent experiments. *P < 0.05.

FIGURE 7 | Key compounds (C0127) in XBJ rescued mice from lethal infection of C. albicans. (A) Survival curves of different groups of mice in Candida infected
(Control) and treatment groups. Control vs. XBJ and Control vs. C0127: P < 0.05. Control group: N = 11; XBJ and C0127 group: N = 12. (B) Colony-forming
assay to evaluate fungal load in kidneys 4 days after Candida infection. *P < 0.05. (C) Hematoxylin and eosin staining to determine the histology in kidneys. Arrows
indicated fungal hyphae in an infected kidney.
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FIGURE 8 | XBJ and C0127 sustained GRP78 expression to improve the survival of 293T cells. (A) C0127 maintained GRP78 expression on protein level in 293T
cells upon C. albicans infection. Western blot experiments were conducted to determine the expression of GRP78. Tubulin was used as an internal control. Lane
1. Control 293T cells; lane 2. C. Albicans infected 293T cells; lane 3. XBJ treated 293T cells; lane 4. C. albicans infected 293T cells treated with C0127; lane 5. C.
albicans infected 293T cells treated with XBJ; lane 6. C0127 treated 293T cells. (B) Quantification of the GRP78 protein in 293T cells upon different treatments.
Data were representative of at least three independent experiments with similar results. (C) Real-time PCR to determine the mRNA expression of GRP78 in 293T
cells upon different treatments. (D) The influence of HA15, a GRP78 inhibitor, on the survival of 293T cells in low serum culture under different conditions by PI
staining. Data were representative of at least three independent experiments with similar results. *P < 0.05.

DISCUSSION

the progression of Candida sepsis. The damaged cells secrete
pro-inflammation cytokines to recruit innate immune cells such
as neutrophils to clear C. albicans (Wirnsberger et al., 2016;
Dominguez-Andres et al., 2017).
Enhancing/activating the function of the innate immune
system counteracts the progression of Candida sepsis by
improving C. albicans clearance. Switching off a series of immune
inhibitory regulators such as the E3 ubiquitin ligase CBLB, Sts,
and Jnk1 significantly improved resistance to C. albicans in
mice (Wirnsberger et al., 2016; Xiao et al., 2016; Zhao et al.,
2017). The E3 ubiquitin ligase CBLB in the innate immune
system negatively impacts the phagocytosis of neutrophils and
macrophages (Wirnsberger et al., 2016; Xiao et al., 2016). The type
I interferon-induced IL-15 production in the Ly6Chigh monocytes
is also required for C. albicans clearance by innate immune cells
(Dominguez-Andres et al., 2017). In contrast, compromising the
function of the innate immune system accelerates C. albicans–
induced kidney failure (Dominguez-Andres et al., 2017).
Other mechanisms that enhance host defense against C.
albicans infection were not extensively studied. Both global
and local inflammation contribute to C. albicans–induced
kidney failure. Li et al. showed the systematic expression of
microRNAs prevented C. albicans infection (Li et al., 2014b; Li
et al., 2018). They found C. albicans induced acute kidney injury

Summary of the Results and Significance

Our network pharmacology analysis predicted that XBJ may
impact fungal infection. XBJ rescued lethal Candida sepsis and
improved kidney epithelial cell survival by maintaining the
expression of GRP78. In addition, C0127, a combination of four
key compounds in XBJ also prevented C. albicans–induced acute
death in mice and the colonization of C. albicans in the kidney. It
improved kidney epithelial cells’ survival by up-regulating GRP78.
These results revealed a novel mechanism of XBJ in preventing
organ failure and cell death. GRP78 was identified as a potential
novel target of XBJ in preventing C. albicans infection. Our results
suggested that network pharmacology is beneficial to identify
novel applications of XBJ and other Chinese medicine formulas.

Mechanism of Kidney Failure in Candida
Sepsis

During the bloodstream infection, C. albicans attaches to the host
and then penetrates the host defense system to attack the target
organs such as the kidney. It is characterized by the presence of
hyphae and the damages to host cells (Brunke and Hube, 2013).
The innate immune system plays an important role in controlling

Frontiers in Pharmacology | www.frontiersin.org

9

January 2020 | Volume 10 | Article 1416

Shang et al.

Xuebijing Prevents Candida sepsis

by attenuating miR-124 expression and up-regulating MIP-1 in
the kidney (Li et al., 2018), indicating local inflammation in the
kidney contributed to kidney failure. Administrating miR-124
mimic inhibited MIP-1 expression in the kidney and restored
kidney functions (Li et al., 2018). It is still not clear how miR-124
and miR-204 regulate innate immune system. However, global
inflammation in the absence of C. albicans may not be sufficient
to induce kidney failure. C. albicans kills kidney epithelial cells
directly, while XBJ partially rescued 293T cell survival upon
C. albicans exposures (Figure 6). This is consistent with our
previous result that XBJ improved RAW264.7 cells survival upon
the insult of LPS (Lyu et al., 2018).

(Wang et al., 1999; Musumeci et al., 2014). A series of publications
indicated XBJ attenuates HMGB1 expression in sepsis organ
injuries (Li et al., 2007; Wang et al., 2007; Wang et al., 2015; Chen
et al., 2016). However, no gain-of-function and loss-of-function
study has been conducted in vivo to determine the influences of
XBJ on these pathways.
XBJ was used to treat and prevent different types of kidney
injuries in the clinic and pre-clinical studies. In a clinical study,
XBJ improved clinical symptoms of sepsis-induced acute kidney
injury (Yuxi et al., 2017). In addition, XBJ attenuated herbicide
paraquat-induced acute kidney injury in rats (Xu et al., 2017).
It also prevented paraquat-induced apoptosis in human kidney
cell line HK-2 (Tian et al., 2018). However, mechanisms of
these effects remain to be illustrated. In this study, we revealed
that XBJ may regulate GRP78 to improve the survival of kidney
epithelial cells upon C. albicans insult and the combination of
four compounds in XBJ can maintain GRP78 expression. This
mechanism may also apply to other organs and cell types.

XBJ and Organ Failure

XBJ has been approved to treat multiple organ dysfunction
syndrome and sepsis in China for over a decade (Gao et al., 2015;
Shi et al., 2017). A Meta-analysis by Song et al. demonstrated
that combining XBJ with conventional intervention is superior
to conventional intervention alone in treating MODS (Song
et al., 2018). The benefits of XBJ to different organs (including
lung, kidney, heart, and liver) were reported in a series of clinical
studies (Fang and Wang, 2013; Wang et al., 2015; Zhang et al.,
2016; Gao et al., 2018; Song et al., 2018) (Song et al., 2019). In
a small-scale prospective, single-center, randomized doubleblinded trial, Gao et al. found XBJ significantly lowered IL-1β,
IL-8, and C-reactive protein in blood and up-regulated IL-10 in
blood and decreased adverse events in patients with lung injury
(Gao et al., 2018). Zhang et al. found XBJ improved myocardial
function in patients with septic myocardial injury, indicated by
improving cardiac troponin I, N-terminal proB-type natriuretic
peptide, and procalcitonin in blood samples of patients (Zhang
et al., 2016).
The major causes of organ failure in sepsis are disseminated
intravascular coagulation (DIC), dysfunction of circulation, and
cytokine storm. Results from basic research confirmed clinical
observations and provided clues to the working mechanism of
XBJ in preventing and treating different types of organ injuries
systemically. It improves microcirculation partially by inhibiting
blood-clotting to prevents/treats organ injuries (Wang et al.,
2015; Xu et al., 2015; Jin et al., 2018). This is reflected in reversing
abnormalities of metabolic biomarkers in sepsis (Shi et al., 2017).
XBJ is also likely to prevent/reverse organ injuries by
improving cell survival and regulating cell functions (Chen et al.,
2013; Li et al., 2014a). Li et al. reported XBJ enhanced survival of
hematopoietic stem cells and mono-nuclear cells upon radiation
insults in vitro and in vivo. XBJ also regulated the secretory
function of Kupffer cells in heat stroke rats (Chen et al., 2013).
At the molecular level, XBJ regulates multiple signaling
pathways to combat organ injuries. It down-regulated TLR4
signaling and stimulated the expression of Toll-interacting
protein to improve organ functions (Liu et al., 2014b; Liu et al.,
2014c; He et al., 2018). XBJ reduced ROS production in rats
to attenuate pulmonary injury (Chen et al., 2017). P38 MAPK
might be a XBJ target in a lung injury model (Liu et al., 2014a).
HMGB1, a nuclear protein related to organ injury, is a biomarker
of organ injury and a potential therapeutic target of organ injury
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The Advantages of Utilizing Different
Methods to Understand the Working
Mechanism of XBJ in Preventing Invasive
C. albicans Infection

Network pharmacology predictions are based on our current
knowledge. The experimental pharmacology has value to
supplement network pharmacology to expand our knowledge.
Our results showed that combining both methods provides
advantages to advance medicine. RNA-seq, real-time PCR, and
Western blot were used to identify novel signaling that impacts
kidney failure during invasive C. albicans infection. GlucoseRegulated Protein 78 (GRP78, BiP) was identified by Western
Blot in 293T cells. Results of real-time PCR confirmed the
influence of XBJ on GRP78 at the transcription level. However,
this result remains to be confirmed in vivo. ATF6B and GRP170,
two ER stress-related proteins were influenced by XBJ in RNAseq. But we did not find their changes on protein level (data
not shown). Whether XBJ influences the expression of GRP94,
another important ER stress protein that shares a similar function
with GRP78 (Zhu and Lee, 2015), is under investigation. Overall,
combining multiple methods is superior to a single method
approach in understanding the working mechanism of XBJ in
preventing invasive C. albicans infection.

ER Stress Pathway in Cell Death and
Organ Failure

GRP78 is a negative regulator of the unfolded protein response
(UPR). Knocking down GRP78 triggered the UPR in un-stressed
cells (Pyrko et al., 2007; Li et al., 2008). GRP78 represses
apoptosis by inhibiting BIK and caspase-7 activation (Reddy
et al., 2003; Fu et al., 2007). The function of GRP78 was not
determined in a kidney-specific knockout animal model yet.
However, its liver-specific knockdown induced liver injury,
suggesting GRP78 plays a role in organ protection and may
render protection for the kidney upon C. albicans insults (Ji et al.,
2011; Chen et al., 2014; Zhu and Lee, 2015). Consistent with the
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literature, inhibiting the function of GRP78 increased the death
of 293T cells (Figure 8). HA15, a specific GRP78 inhibitor, did
not induce a dramatic increase of 293T cell death. This may due
to the redundant function of GRP78 and GRP94 (Zhu and Lee,
2015). This hypothesis remains to be tested.

ER stress–dependent apoptotic signaling pathway in MCAO rats
(Gu et al., 2016). Hydroxysafflor yellow A (HSYA) plays a role in
preventing tissue injuries (Han et al., 2017). Bai et al. reported the
protective effect of HSYA on acute kidney injury in an ischemia/
reperfusion (I/R) model. They found HSYA prevented I/R induced
apoptosis in kidney epithelial cells in vivo and in vitro. HSYA
may attenuate TLR4 signaling to prevent apoptosis in kidney
epithelial cells (Bai et al., 2018). Increasing the stability of HSYA
in XBJ may further enhance the protection to the kidney (Pu
et al., 2017). In our experiment, XBJ or C0127 does not inhibit C.
albicans growth in vitro. This is consistent with the observation of
Canturk which showed 1mg/ml ferulic acid-induced necrosis in
C. albicans and it synergistically enhanced the anti-fungal effect
of caspofungin (Canturk, 2018). Thus, low conc. of ferulic acid
is unlikely to influence the survival of C. albicans in systematic
infection. The combination of four compounds does not have a
synergistic inhibition on the growth of C. albicans in vitro either
(data not shown).

Network Pharmacology in Developing
Novel Regimens to Prevent Fungal
Infection

Network pharmacology may shed light on developing novel
Chinese medicine (Lyu et al., 2017; Suo et al., 2017). In this
study, it also provided hints for a potential application of XBJ.
Our aim was to take the advantages of network pharmacology
to reveal a novel mechanism of XBJ in preventing invasive
fungal infection. ER stress signaling was not predicted as top
signaling related to invasive fungal infection by our network
pharmacology analysis. In addition, our literature mining did
not retrieve strong evidence indicating an important role of ER
stress signaling in invasive fungal infection. It emerged from our
RNA-seq analysis using RNA extracted from 293T cells in the
presence of C. albicans and XBJ treatments. The alteration of
GRP78 was more pronounced on the protein level rather than
the transcription level in C. albicans–infected 293T cells treated
by XBJ. However, Western Blot confirmed XBJ and C0127 did
sustain the expression of GRP78 (Figures 6 and 8). Hence,
our new finding indicated network pharmacology analysis
and experiments complemented each other in illustrating
the mechanism of compound Chinese medicine in treating
human diseases.

Future Directions

Our network pharmacology analysis predicted that XBJ regulates
type I interferon and its upstream regulators such as interferon
α, TLR2, and TLR4 in invasive fungal infection (Figures 3B, C).
Thus, we hypothesized that XBJ may regulate type I interferon
signaling in the innate immune system to enhance the clearance
of C. albicans in invasive C. albicans infection. XBJ and C0127
may regulate innate immune system to enhance the survival of
Candida infected mice while enhancing the survival of kidney
epithelial cells. We also aim to determine how XBJ and C0127
regulate the innate immune cells and whether type I interferon
signaling mediates their effects.

C0127 Prevents C. albicans–Induced
Kidney Failure

Our network pharmacology analysis predicted that four
compounds in XBJ regulated 2/3 of predicted XBJ targets in
fungal infection (Figure 3A and Supplementary Figure 2). This
prediction was confirmed in our in vivo study (Figure 7). C0127
not only prevented Candida sepsis but also prevented C. albicans
colonization in the kidney. Paeoniflorin and hydroxysafflor yellow
A, the top two high-concentration compounds in XBJ, may play
major roles in preventing kidney failure upon systemic C. albicans
infection. Paeoniflorin which claims the highest concentration
in XBJ was isolated from Chishao (Liu et al., 2015; Han et al.,
2017). Several groups reported that paeoniflorin attenuates ER
stress in different tissues and organs (Chen et al., 2018a; Gu
et al., 2016; Jiang et al., 2014; Zhu et al., 2018). Gu et al. indicated
paeoniflorin exerted protection for MCAO rats by regulating ER
stress. Zhu et al. reported that paeoniflorin attenuates ER stress
in retinal pigment epithelial cells via triggering Ca(2+)/CaMKIIdependent activation of AMPK (Zhu et al., 2018). It is likely that
paeoniflorin plays a major role in regulating the expression of
GRP78 in kidney epithelial cells. However, this was not verified
by our in vitro experiments. Paeoniflorin did not significantly
enhance the expression of GRP78 individually (data not shown).
Consistent with our results, Gu et al. found that a combination of
L. chuanxiong and Radix paeoniae, two herbs in XBJ, attenuated
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CONCLUSIONS
In conclusion, XBJ may prevent systemic C. albicans infection in
sepsis patients. Compounds with higher concentrations in XBJ
played major roles in preventing Candida induced kidney failure.
GRP78 is a novel target of XBJ and C0127 in kidney epithelial
cells. Members of ER stress signaling might be novel therapeutic
targets in organ protection and sepsis.

ETHICS STATEMENT
This study was carried out in accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals (NIH Publication No. 85-23, revised 1996,
USA) and the recommendations in the Guidance for the Care
and Use of Laboratory Animals issued by the Ministry of Science
and Technology of China. All experiments were approved by
the Institutional Animal Care and Use Committee of Nankai
University and the Laboratory Animal Ethics Committee of the
Tianjin University of Traditional Chinese Medicine (Tianjin,
china) and were performed in accordance with its guidelines
(Permit Number: TCM-LAE-20170017).

11

January 2020 | Volume 10 | Article 1416

Shang et al.

Xuebijing Prevents Candida sepsis

AUTHOR CONTRIBUTIONS

Tianjin Municipal Education Commission (Grant number:
TD13-5046).

QY, YF, and M-CL designed the study and developed the
methodologies. TS, QY, YF, TR, X-TW, HZ and J-MG conducted
research. QY, YF, TS, TR, HZ, X-TW, J-MG, GP, XG, YZ and
M-C.L. analyzed the data and contributed critical reagents. QY,
YF, YZ, TS, and M-CL wrote and revised the manuscript.

ACKNOWLEDGMENTS
We thank our colleagues for their supports. We thank Zhengcan
Zhou, Dr. Shuang He, Ming Lyu, Yu-Le Wang, Guang-Xu
Xiao, and Xin-Yan Liu for their technical supports and
constructive discussions. We thank Dr. John Orgh for editing
our manuscript.

FUNDING
This project was supported by the National Science
Foundation of China (Grant number: 81774018, 81973581,
81873037, 31670146, 81873961); Tianjin University of
Traditional Chinese Medicine (Startup Grant for Y.F.); Nankai
University (The Open Fund of Ministry of Education Key
Laboratory of Molecular Microbiology and Technology);

SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online at:
https://www.frontiersin.org/articles/10.3389/fphar.2019.01416/
full#supplementary-material

REFERENCES

Cheng, C., Lin, J. Z., Li, L., Yang, J. L., Jia, W. W., Huang, Y. H., et al. (2016).
Pharmacokinetics and disposition of monoterpene glycosides derived from
Paeonia lactiflora roots (Chishao) after intravenous dosing of antiseptic
XueBiJing injection in human subjects and rats. Acta Pharmacol. Sin. 37, 530–
544. doi: 10.1038/aps.2015.103
Diekema, D., Arbefeville, S., Boyken, L., Kroeger, J., and Pfaller, M. (2012).
The changing epidemiology of healthcare-associated candidemia over
three decades. Diagn. Microbiol. Infect. Dis. 73, 45–48. doi: 10.1016/j.
diagmicrobio.2012.02.001
Dominguez-Andres, J., Feo-Lucas, L., Minguito de la Escalera, M., Gonzalez,
L., Lopez-Bravo, M., and Ardavin, C. (2017). Inflammatory Ly6C(high)
monocytes protect against candidiasis through IL-15-driven NK cell/neutrophil
Activation. Immunity 46, 1059–1072 e1054. doi: 10.1016/j.immuni.2017.05.009
Dong, Y., Zhang, D., Yu, Q., Zhao, Q., Xiao, C., Zhang, K., et al. (2017). Loss of
Ssq1 leads to mitochondrial dysfunction, activation of autophagy and cell
cycle arrest due to iron overload triggered by mitochondrial iron-sulfur cluster
assembly defects in Candida albicans. Int. J. Biochem. Cell Biol. 85, 44–55. doi:
10.1016/j.biocel.2017.01.021
Fang, K., and Wang, X. L. (2013). Treatment of multiple organ dysfunction
syndrome by Xuebijing Injection: a clinical research. Zhongguo Zhong Xi Yi Jie
He Za Zhi 33, 205–207.
Fu, Y., Li, J., and Lee, A. S. (2007). GRP78/BiP inhibits endoplasmic reticulum BIK
and protects human breast cancer cells against estrogen starvation-induced
apoptosis. Cancer Res. 67, 3734–3740. doi: 10.1158/0008-5472.CAN-06-4594
Gao, J., Kong, L., Liu, S., Feng, Z., Shen, H., Liu, Q., et al. (2015). A prospective
multicenter clinical study of Xuebijing injection in the treatment of sepsis and
multiple organ dysfunction syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
27, 465–470. doi: 10.3760/cma.j.issn.2095-4352.2015.06.010
Gao, W., Li, N., and Cui, X. G. (2018). Efficacy of xuebijing injection on
cardiopulmonary bypass-associated pulmonary injury: a prospective, singlecenter, randomized, double blinded trial. Chin. J. Integr. Med. 24, 815–821. doi:
10.1007/s11655-018-2933-7
Gao, S. (2010). The therapeutic effect of Xuebijing on fungal pneumonia. Nei Mongol
J. Tradit. Chin. Med. 2, 62–63. doi: 10.16040/j.cnki.cn15-1101.2010.09.132
Gray, M. J., Mhawech-Fauceglia, P., Yoo, E., Yang, W., Wu, E., Lee, A. S., et al. (2013).
AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and
contribution to chemoresistance in endometrial cancers. Int. J. Cancer 133,
21–30. doi: 10.1002/ijc.27994
Gu, J., Chen, J., Yang, N., Hou, X., Wang, J., Tan, X., et al. (2016). Combination of
ligusticum chuanxiong and radix paeoniae ameliorate focal cerebral ischemic
in MCAO rats via endoplasmic reticulum stress-dependent apoptotic signaling
pathway. J. Ethnopharmacol. 187, 313–324. doi: 10.1016/j.jep.2016.04.024
Guo, Y., Wang, Y., Huang, X., Lv, H., Fan, R., Huang, W., et al. (2014). Determination
of hydroxysafflor yellow a in biological fluids of patients with traumatic brain

Bai, J., Zhao, J., Cui, D., Wang, F., Song, Y., Cheng, L., et al. (2018). Protective effect
of hydroxysafflor yellow A against acute kidney injury via the TLR4/NF-kappaB
signaling pathway. Sci. Rep. 8, 9173. doi: 10.1038/s41598-018-27217-3
Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G., and White,
T. C. (2012). Hidden killers: human fungal infections. Sci. Transl. Med. 4,
165rv113. doi: 10.1126/scitranslmed.3004404
Brunke, S., and Hube, B. (2013). Two unlike cousins: candida albicans and C.
glabrata infection strategies. Cell Microbiol. 15, 701–708. doi: 10.1111/
cmi.12091
Canturk, Z. (2018). Evaluation of synergistic anticandidal and apoptotic effects of
ferulic acid and caspofungin against Candida albicans. J. Food Drug Anal. 26,
439–443. doi: 10.1016/j.jfda.2016.12.014
Cao, Y. (2017). 27 Cases of fungal pneumonia treated with xuebijing and
fluconazole modern journal of integrative traditional chinese and western
medicine. 17 (64), 125. doi: 10.19613/j.cnki.1671-3141.2017.64.107
Cerezo, M., Lehraiki, A., Millet, A., Rouaud, F., Plaisant, M., Jaune, E., et al.
(2016). Compounds triggering ER stress exert anti-melanoma effects and
overcome BRAF inhibitor resistance. Cancer Cell 29, 805–819. doi: 10.1016/j.
ccell.2016.04.013
Chen, G., Gao, Y., Jiang, Y., Yang, F., Li, S., Tan, D., et al. (2018a). Efficacy and
safety of xuebijing injection combined with ulinastatin as adjunctive therapy
on sepsis: a systematic review and meta-analysis. Front. Pharmacol. 9, 743.
Chen, Y., Tong, H., Zhang, X., Tang, L., Pan, Z., Liu, Z., et al. (2013). Xuebijing
injection alleviates liver injury by inhibiting secretory function of Kupffer
cells in heat stroke rats. J. Tradit. Chin. Med. 33, 243–249. doi: 10.1016/
S0254-6272(13)60133-8
Chen, W. T., Zhu, G., Pfaffenbach, K., Kanel, G., Stiles, B., and Lee, A. S. (2014).
GRP78 as a regulator of liver steatosis and cancer progression mediated by
loss of the tumor suppressor PTEN. Oncogene 33, 4997–5005. doi: 10.1038/
onc.2013.437
Chen, S., Dai, G., Hu, J., Rong, A., Lv, J., Su, L., et al. (2016). Discovery of xuebijing
injection exhibiting protective efficacy on sepsis by inhibiting the expression
of HMGB1 in septic rat model designed by cecal ligation and puncture. Am. J.
Ther. 23, e1819–e1825. doi: 10.1097/MJT.0000000000000296
Chen, Y., Tong, H., Pan, Z., Jiang, D., Zhang, X., Qiu, J., et al. (2017). Xuebijing
injection attenuates pulmonary injury by reducing oxidative stress and
proinflammatory damage in rats with heat stroke. Exp. Ther. Med. 13, 3408–
3416. doi: 10.3892/etm.2017.4444
Chen, X., Feng, Y., Shen, X., Pan, G., Fan, G., Gao, X., et al. (2018). Anti-sepsis
protection of Xuebijing injection is mediated by differential regulation of pro- and
anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial
sepsis. J. Ethnopharmacol. 211, 358–365. doi: 10.1016/j.jep.2017.10.001

Frontiers in Pharmacology | www.frontiersin.org

12

January 2020 | Volume 10 | Article 1416

Shang et al.

Xuebijing Prevents Candida sepsis

injury by UPLC-ESI-MS/MS after injection of Xuebijing. BioMed. Chromatogr.
28, 1090–1095. doi: 10.1002/bmc.3124
Han, J. Y., Li, Q., Ma, Z. Z., and Fan, J. Y. (2017). Effects and mechanisms of
compound Chinese medicine and major ingredients on microcirculatory
dysfunction and organ injury induced by ischemia/reperfusion. Pharmacol.
Ther. 177, 146–173. doi: 10.1016/j.pharmthera.2017.03.005
He, F., Wang, J., Liu, Y., Wang, X., Cai, N., Wu, C., et al. (2018). Xuebijing injection
induces anti-inflammatory-like effects and downregulates the expression of
TLR4 and NF-kappaB in lung injury caused by dichlorvos poisoning. BioMed.
Pharmacother. 106, 1404–1411. doi: 10.1016/j.biopha.2018.07.111
Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., et al.
(2016). Prevalent mutator genotype identified in fungal pathogen Candida
glabrata promotes multi-drug resistance. Nat. Commun. 7, 11128. doi: 10.1038/
ncomms11128
Hu, H. X., Zhu, M. Q., Sun, Y. C., Ma, C., Wang, X., and Liu, X. L. (2018). Xuebijing
enhances neuroprotective effects of ulinastatin on transient cerebral ischemia
via Nrf2-are signal pathways in the hippocampus. J. Biol. Regul. Homeost.
Agents 32, 1143–1149.
Huang, H., Ji, L., Song, S., Wang, J., Wei, N., Jiang, M., et al. (2011). Identification
of the major constituents in Xuebijing injection by HPLC-ESI-MS. Phytochem.
Anal. 22, 330–338. doi: 10.1002/pca.1284
Ji, C., Kaplowitz, N., Lau, M. Y., Kao, E., Petrovic, L. M., and Lee, A. S. (2011). Liverspecific loss of glucose-regulated protein 78 perturbs the unfolded protein
response and exacerbates a spectrum of liver diseases in mice. Hepatology 54,
229–239. doi: 10.1002/hep.24368
Jiang, M., Zhou, M., Han, Y., Xing, L., Zhao, H., Dong, L., et al. (2013). Identification
of NF-kappaB Inhibitors in Xuebijing injection for sepsis treatment based
on bioactivity-integrated UPLC-Q/TOF. J. Ethnopharmacol. 147, 426–433.
doi: 10.1016/j.jep.2013.03.032
Jiang, Z., Chen, W., Yan, X., Bi, L., Guo, S., and Zhan, Z. (2014). Paeoniflorin
protects cells from GalN/TNF-alpha-induced apoptosis via ER stress and
mitochondria-dependent pathways in human L02 hepatocytes. Acta. Biochim.
Biophys. Sin (Shanghai) 46 (5), 357–367 doi: 10.1093/abbs/gmu010
Jin, H., Chen, Y., Ding, C., Lin, Y., Chen, Y., Jiang, D., et al. (2018). Microcirculatory
disorders and protective role of Xuebijing in severe heat stroke. Sci. Rep. 8,
4553. doi: 10.1038/s41598-018-22812-w
Kramer, A., Green, J., Pollard, J.Jr., and Tugendreich, S. (2014). Causal analysis
approaches in ingenuity pathway analysis. Bioinformatics 30, 523–530. doi:
10.1093/bioinformatics/btt703
Kullberg, B. J., and Arendrup, M. C. (2015). Invasive candidiasis. N. Engl. J. Med.
373, 1445–1456. doi: 10.1056/NEJMra1315399
Lewy, T. G., Grabowski, J. M., and Bloom, M. E. (2017). BiP: master regulator of
the unfolded protein response and crucial factor in flavivirus biology. Yale J.
Biol. Med. 90, 291–300.
Li, Y. P., Qiao, Y. J., Wu, Z. X., Yao, Y. M., Yu, Y., and Wu, Y. (2007). Effects of
Xuebijing injection on high-mobility group box chromosomal protein 1 in
septic rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19, 239–241. doi: 10.3760/j.
issn:1003-0603.2007.04.013
Li, J., Ni, M., Lee, B., Barron, E., Hinton, D. R., and Lee, A. S. (2008). The unfolded
protein response regulator GRP78/BiP is required for endoplasmic reticulum
integrity and stress-induced autophagy in mammalian cells. Cell Death Differ.
15, 1460–1471. doi: 10.1038/cdd.2008.81
Li, D., Lu, L., Zhang, J., Wang, X., Xing, Y., Wu, H., et al. (2014a). Mitigating the
effects of Xuebijing injection on hematopoietic cell injury induced by total
body irradiation with gamma rays by decreasing reactive oxygen species levels.
Int. J. Mol. Sci. 15, 10541–10553. doi: 10.3390/ijms150610541
Li, X. Y., Zhang, K., Jiang, Z. Y., and Cai, L. H. (2014b). MiR-204/miR-211
downregulation contributes to candidemia-induced kidney injuries via
derepression of Hmx1 expression. Life Sci. 102, 139–144. doi: 10.1016/j.
lfs.2014.03.010
Li, X., Cheng, C., Wang, F., Huang, Y., Jia, W., Olaleye, O. E., et al. (2016).
Pharmacokinetics of catechols in human subjects intravenously receiving
XueBiJing injection, an emerging antiseptic herbal medicine. Drug Metab.
Pharmacokinet. 31, 95–98. doi: 10.1016/j.dmpk.2015.10.005
Li, X. Y., Zhang, Y. Q., Xu, G., Li, S. H., and Li, H. (2018). miR-124/MCP-1 signaling
pathway modulates the protective effect of itraconazole on acute kidney injury
in a mouse model of disseminated candidiasis. Int. J. Mol. Med. 41, 3468–3476.
doi: 10.3892/ijmm.2018.3564

Frontiers in Pharmacology | www.frontiersin.org

Li, J., Olaleye, O. E., Yu, X., Jia, W., Yang, J., Lu, C., et al. (2019). High degree
of pharmacokinetic compatibility exists between the five-herb medicine
XueBiJing and antibiotics comedicated in sepsis care. Acta Pharm. Sin. B. 9,
1035–1049. doi: 10.1016/j.apsb.2019.06.003
Liang, C., Zhang, B., Cui, L., Li, J., Yu, Q., and Li, M. (2018). Mgm1 is required
for maintenance of mitochondrial function and virulence in Candida albicans.
Fungal Genet. Biol. 120, 42–52. doi: 10.1016/j.fgb.2018.09.006
Liu, R., Li, X., Gao, W., Zhou, Y., Wey, S., Mitra, S. K., et al. (2013). Monoclonal
antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT
signaling, tumor growth, and metastasis. Clin. Cancer Res. 19, 6802–6811. doi:
10.1158/1078-0432.CCR-13-1106
Liu, M. W., Su, M. X., Zhang, W., Wang, Y. Q., Chen, M., Wang, L., et al. (2014a).
Protective effect of Xuebijing injection on paraquat-induced pulmonary injury
via down-regulating the expression of p38 MAPK in rats. BMC Complement
Altern. Med. 14, 498. doi: 10.1186/1472-6882-14-498
Liu, Y. K., He, J. B., Chen, H. E., Chen, D., Miao, Y. F., Ying, L., et al. (2014b).
Effect of Xuebijing Injection on TLR4-NF-kappaB-TNF-alpha pathway of rats’
myocardial anoxia/reoxygenation. Zhongguo Zhong Xi Yi Jie He Za Zhi 34,
1463–1468. doi: 10.7661/CJIM.2014.12.1463
Liu, Y. K., Huang, L. J., Zhao, S., Lin, W., He, J. B., Ying, L., et al. (2014c). Effect of
Xuebijing injection on TLR4-NF-kappaB-IL-1beta pathway of myocardial
hypoxia/reoxygenation in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 30, 55–59.
doi: 10.13459/j.cnki.cjap.2014.01.007
Liu, Y. C., Yao, F. H., Chai, Y. F., Dong, N., Sheng, Z. Y., and Yao, Y. M. (2015).
Xuebijing injection promotes M2 polarization of macrophages and improves
survival rate in septic mice. Evid. Based Complement Alternat. Med. 2015,
352642. doi: 10.1155/2015/352642
Lyu, M., Yan, C. L., Liu, H. X., Wang, T. Y., Shi, X. H., Liu, J. P., et al. (2017).
Network pharmacology exploration reveals endothelial inflammation as a
common mechanism for stroke and coronary artery disease treatment of
Danhong injection. Sci. Rep. 7, 15427. doi: 10.1038/s41598-017-14692-3
Lyu, M., Zhou, Z., Wang, X., Lv, H., Wang, M., Pan, G., et al. (2018). Network
pharmacology-guided development of a novel integrative regimen to
prevent acute graft-vs.-host disease. Front. Pharmacol. 9, 1440. doi: 10.3389/
fphar.2018.01440
Musumeci, D., Roviello, G. N., and Montesarchio, D. (2014). An overview
on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related
pathologies. Pharmacol. Ther. 141, 347–357. doi: 10.1016/j.pharmthera.
2013.11.001
Pfaller, M. A., and Diekema, D. J. (2010). Epidemiology of invasive
mycoses in North America. Crit. Rev. Microbiol. 36, 1–53. doi: 10.3109/
10408410903241444
Pu, W., Zhang, H., Wang, M., Liu, Y., Sun, L., and Ren, X. (2017). Superior stability
of hydroxysafflor yellow a in xuebijing injection and the associated mechanism.
Molecules 22 (12), 2129. doi: 10.3390/molecules22122129
Pyrko, P., Schonthal, A. H., Hofman, F. M., Chen, T. C., and Lee, A. S. (2007).
The unfolded protein response regulator GRP78/BiP as a novel target for
increasing chemosensitivity in malignant gliomas. Cancer Res. 67, 9809–9816.
doi: 10.1158/0008-5472.CAN-07-0625
Reddy, R. K., Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., and Lee,
A. S. (2003). Endoplasmic reticulum chaperone protein GRP78 protects cells
from apoptosis induced by topoisomerase inhibitors: role of ATP binding site
in suppression of caspase-7 activation. J. Biol. Chem. 278, 20915–20924. doi:
10.1074/jbc.M212328200
Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., et al. (2014). TCMSP: a database
of systems pharmacology for drug discovery from herbal medicines. J.
Cheminform. 6, 13. doi: 10.1186/1758-2946-6-13
Ruggiero, C., Doghman-Bouguerra, M., Ronco, C., Benhida, R., Rocchi, S., and
Lalli, E. (2018). The GRP78/BiP inhibitor HA15 synergizes with mitotane
action against adrenocortical carcinoma cells through convergent activation
of ER stress pathways. Mol. Cell Endocrinol. 474, 57–64. doi: 10.1016/j.
mce.2018.02.010
Sakagami, T., Kawano, T., Yamashita, K., Yamada, E., Fujino, N., Kaeriyama, M., et al.
(2018). Antifungal susceptibility trend and analysis of resistance mechanism
for Candida species isolated from bloodstream at a Japanese university hospital.
J. Infect. Chemother 25 (1), 34–40. doi: 10.1016/j.jiac.2018.10.007
Shani, G., Fischer, W. H., Justice, N. J., Kelber, J. A., Vale, W., and Gray, P. C. (2008).
GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit

13

January 2020 | Volume 10 | Article 1416

Shang et al.

Xuebijing Prevents Candida sepsis

transforming growth factor beta signaling and enhance cell growth. Mol. Cell
Biol. 28, 666–677. doi: 10.1128/MCB.01716-07
Shi, H., Hong, Y., Qian, J., Cai, X., and Chen, S. (2017). Xuebijing in the treatment
of patients with sepsis. Am. J. Emerg. Med. 35, 285–291. doi: 10.1016/j.
ajem.2016.11.007
Song, R., Dong, C., Wang, C., Zhang, H., and Yang, Z. (2018). Effectiveness of
Xuebijing in treatment of multiple organ dysfunction syndrome: a Meta
analysis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 30, 848–854. doi: 10.3760/cma
.j.issn.2095-4352.2018.09.006
Song, Y., Yao, C., Yao, Y., Han, H., Zhao, X., Yu, K., et al. (2019). XueBiJing Injection
Versus Placebo for Critically Ill Patients With Severe Community-Acquired
Pneumonia: A Randomized Controlled Trial. Crit. Care Med. 47, e735–e743.
doi: 10.1097/CCM.0000000000003842
Spellberg, B., Ibrahim, A. S., Edwards, J. E.Jr., and Filler, S. G. (2005). Mice with
disseminated candidiasis die of progressive sepsis. J. Infect. Dis. 192, 336–343.
doi: 10.1086/430952
Stelzer, G., Dalah, I., Stein, T. I., Satanower, Y., Rosen, N., Nativ, N., et al. (2011).
In-silico human genomics with GeneCards. Hum. Genomics 5, 709–717. doi:
10.1186/1479-7364-5-6-709
Suo, T., Liu, J., Chen, X., Yu, H., Wang, T., Li, C., et al. (2017). Combining chemical
profiling and network analysis to investigate the pharmacology of complex
prescriptions in traditional chinese medicine. Sci. Rep. 7, 40529. doi: 10.1038/
srep40529
Tian, X., Zhang, W. L., Hu, L. L., She, X. R., Hong, G. L., Chen, L. M., et al. (2018).
The protective effect of Xuebijing on paraquat-induced HK-2 cells apoptosis
and the underlying mechanisms. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing
Za Zhi 36, 1–6. doi: 10.3760/cma.j.issn.1001-9391.2018.01.001
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J.,
et al. (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science
285, 248–251. doi: 10.1126/science.285.5425.248
Wang, Q., Yao, Y. M., Wang, W. J., Xian, L. M., Dong, N., Xu, S., et al. (2007). Effect
of Xuebijing injection on renal high mobility group box-1 protein expression
and acute kidney injury in rats after scald injury. Zhongguo Yi Xue Ke Xue Yuan
Xue Bao 29, 478–483. doi: 10.3760/j.issn:0529-5815.2007.17.018
Wang, Q., Wu, X., Tong, X., Zhang, Z., Xu, B., and Zhou, W. (2015). Xuebijing
Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and
RAGE Expressions in Mice. Evid. Based Complement Alternat. Med. 2015,
860259. doi: 10.1155/2015/860259
Wang, J. W. (2010). Efficiency and security of amphotericin b plus xuebijing
injection in early empirical treatment of invasive fungal infection in ICU. Chin.
J. Med. Guide 12, 2. doi: 10.3969/j.issn.1009-0959.2010.11.055
Wirnsberger, G., Zwolanek, F., Asaoka, T., Kozieradzki, I., Tortola, L., Wimmer,
R. A., et al. (2016). Inhibition of CBLB protects from lethal Candida albicans
sepsis. Nat. Med. 22, 915–923. doi: 10.1038/nm.4134
Xiao, Y., Tang, J., Guo, H., Zhao, Y., Tang, R., Ouyang, S., et al. (2016). Targeting
CBLB as a potential therapeutic approach for disseminated candidiasis. Nat.
Med. 22, 906–914. doi: 10.1038/nm.4141
Xu, Q., Liu, J., Guo, X., Tang, Y., Zhou, G., Liu, Y., et al. (2015). Xuebijing injection
reduces organ injuries and improves survival by attenuating inflammatory
responses and endothelial injury in heatstroke mice. BMC Complement Altern.
Med. 15, 4. doi: 10.1186/s12906-015-0519-5

Frontiers in Pharmacology | www.frontiersin.org

Xu, J. J., Zhen, J. T., Tang, L., and Lin, Q. M. (2017). Intravenous injection of Xuebijing
attenuates acute kidney injury in rats with paraquat intoxication. World J.
Emerg. Med. 8, 61–64. doi: 10.5847/wjem.j.1920-8642.2017.01.011
Xue, R., Fang, Z., Zhang, M., Yi, Z., Wen, C., and Shi, T. (2013). TCMID: Traditional
Chinese Medicine integrative database for herb molecular mechanism analysis.
Nucleic Acids Res. 41, D1089–D1095. doi: 10.1093/nar/gks1100
Yu, Q., Jia, C., Dong, Y., Zhang, B., Xiao, C., Chen, Y., et al. (2015). Candida albicans
autophagy, no longer a bystander: Its role in tolerance to ER stress-related
antifungal drugs. Fungal Genet. Biol. 81, 238–249. doi: 10.1016/j.fgb.2015.02.008
Yuxi, Q., Zhang, H., Baili, Y., and Shi, S. (2017). Effects of Xuebijing Injection
for Patients With Sepsis-induced Acute Kidney Injury After Wenchuan
Earthquake. Altern. Ther. Health Med. 23, 36–42.
Zhang, H., Wei, L., Zhao, G., Liu, S., Zhang, Z., Zhang, J., et al. (2016). Protective
effect of Xuebijing injection on myocardial injury in patients with sepsis: a
randomized clinical trial. J. Tradit. Chin. Med. 36, 706–710. doi: 10.1016/
S0254-6272(17)30003-1
Zhang, N., Cheng, C., Olaleye, O.E., Sun, Y., Li, L., Huang, Y., et al. (2018).
Pharmacokinetics-Based Identification of Potential Therapeutic Phthalides
from XueBiJing, a Chinese Herbal Injection Used in Sepsis Management. Drug
Metab. Dispos. 46, 823–834.
Zhao, X., Guo, Y., Jiang, C., Chang, Q., Zhang, S., Luo, T., et al. (2017). JNK1
negatively controls antifungal innate immunity by suppressing CD23
expression. Nat. Med. 23, 337–346. doi: 10.1038/nm.4260
Zhu, G., and Lee, A. S. (2015). Role of the unfolded protein response, GRP78 and
GRP94 in organ homeostasis. J. Cell Physiol. 230, 1413–1420. doi: 10.1002/
jcp.24923
Zhu, X., Wang, K., Zhou, F., and Zhu, L. (2018). Paeoniflorin attenuates atRALinduced oxidative stress, mitochondrial dysfunction and endoplasmic
reticulum stress in retinal pigment epithelial cells via triggering Ca(2+)/
CaMKII-dependent activation of AMPK. Arch. Pharm. Res. 41, 1009–1018.
doi: 10.1007/s12272-018-1059-6
Zuo, L., Zhong, Q., Wang, Z., Sun, Z., Zhou, L., Li, Z., et al. (2017). Simultaneous
determination and pharmacokinetic study of twelve bioactive compounds in
rat plasma after intravenous administration of Xuebijing injection by UHPLCQ-Orbitrap HRMS. J. Pharm. BioMed. Anal. 146, 347–353. doi: 10.1016/j.
jpba.2017.09.010
Zuo, L., Zhou, L., Xu, T., Li, Z., Liu, L., Shi, Y., et al. (2018). Antiseptic activity of
ethnomedicinal Xuebijing revealed by the metabolomics analysis using UHPLCQ-Orbitrap HRMS. Front. Pharmacol. 9, 300. doi: 10.3389/fphar.2018.00300
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Shang, Yu, Ren, Wang, Zhu, Gao, Pan, Gao, Zhu, Feng and Li.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.

14

January 2020 | Volume 10 | Article 1416

